MWM
GILD icon

Maridea Wealth Management’s Gilead Sciences GILD Stock Holding History

Maridea Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,900
Closed -$234K – 423
2025
Q3 		$234K Sell
1,900
-2,921
-61% -$332K 0.04% 374
2025
Q2 		$535K Buy
4,821
+524
+12% +$55.8K 0.14% 142
2025
Q1 		$482K Sell
4,297
-1,076
-20% -$111K 0.16% 130
2024
Q4 		$496K Buy
+5,373
New +$484K 0.16% 110

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Maridea Wealth Management's GILD Position: Q4 2025 in Review

Maridea Wealth Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 1,900 shares — an estimated $234K sold.

Maridea Wealth Management first reported a position in GILD in Q4 2024 and held it in 4 quarters. The position peaked at $535K in Q2 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Maridea Wealth Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Maridea Wealth Management sold 1,900 Gilead Sciences shares in Q4 2025, an estimated $234K.
  • Maridea Wealth Management first reported a position in Gilead Sciences in Q4 2024 and held it in 4 quarters.
  • Maridea Wealth Management's Gilead Sciences position peaked at $535K in Q2 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Maridea Wealth Management's 13F filing for Q4 2025, filed 8 Jan 2026.